Nasopharyngeal Cancinoma (NPC) Clinical Trials in Shenzhen, Guangdong
4 recruitingShenzhen, Guangdong, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Nasopharangeal CancerNasopharyngeal Cancinoma (NPC)
Sun Yat-sen University55 enrolled2 locationsNCT07325539
Recruiting
International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
Nasopharyngeal Cancinoma (NPC)
The University of Hong Kong-Shenzhen Hospital5,000 enrolled1 locationNCT07013461
Recruiting
Phase 3
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University700 enrolled6 locationsNCT07201337
Recruiting
Phase 2
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University243 enrolled4 locationsNCT07362979